ITRM20040268A1 - Formulazione farmaceutica di una soluzione stabile di formoterolo per via inalatoria e suo precedimento di preparazione. - Google Patents

Formulazione farmaceutica di una soluzione stabile di formoterolo per via inalatoria e suo precedimento di preparazione.

Info

Publication number
ITRM20040268A1
ITRM20040268A1 ITRM20040268A ITRM20040268A1 IT RM20040268 A1 ITRM20040268 A1 IT RM20040268A1 IT RM20040268 A ITRM20040268 A IT RM20040268A IT RM20040268 A1 ITRM20040268 A1 IT RM20040268A1
Authority
IT
Italy
Prior art keywords
inhalation
preparation
pharmaceutical formulation
stable
formoterol solution
Prior art date
Application number
Other languages
English (en)
Inventor
Raffaele Annaloro
Achille Sonaglia
Original Assignee
Italchimici S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Italchimici S P A filed Critical Italchimici S P A
Priority to ITRM20040268 priority Critical patent/ITRM20040268A1/it
Publication of ITRM20040268A1 publication Critical patent/ITRM20040268A1/it
Priority to EP04425739A priority patent/EP1604657A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ITRM20040268 2004-05-31 2004-05-31 Formulazione farmaceutica di una soluzione stabile di formoterolo per via inalatoria e suo precedimento di preparazione. ITRM20040268A1 (it)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ITRM20040268 ITRM20040268A1 (it) 2004-05-31 2004-05-31 Formulazione farmaceutica di una soluzione stabile di formoterolo per via inalatoria e suo precedimento di preparazione.
EP04425739A EP1604657A1 (en) 2004-05-31 2004-10-04 Pharmaceutical formulation of a stable Formoterol-containing solution for use in inhalation therapy and method of preparing it

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM20040268 ITRM20040268A1 (it) 2004-05-31 2004-05-31 Formulazione farmaceutica di una soluzione stabile di formoterolo per via inalatoria e suo precedimento di preparazione.

Publications (1)

Publication Number Publication Date
ITRM20040268A1 true ITRM20040268A1 (it) 2004-08-31

Family

ID=34932800

Family Applications (1)

Application Number Title Priority Date Filing Date
ITRM20040268 ITRM20040268A1 (it) 2004-05-31 2004-05-31 Formulazione farmaceutica di una soluzione stabile di formoterolo per via inalatoria e suo precedimento di preparazione.

Country Status (2)

Country Link
EP (1) EP1604657A1 (it)
IT (1) ITRM20040268A1 (it)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11432569B2 (en) * 2019-10-31 2022-09-06 Iti Technologies, Inc. Domestic animal water and feed modifying compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1150890C (zh) * 1998-08-04 2004-05-26 杰格研究股份公司 药用气溶胶制剂
HRP20010255A2 (en) * 1998-10-17 2002-04-30 Boehringer Ingelheim Pharma Storable active substance concentrate with formoterol
IT1313553B1 (it) * 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
ITMI20010428A1 (it) * 2001-03-02 2002-09-02 Chemo Breath S A Composizioni ad uso inalatorio a base di formoterolo
US20030055026A1 (en) * 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
ITRM20010614A1 (it) * 2001-10-16 2003-04-16 Italchimici S P A Preparazione farmaceutica di una soluzione idro/propilenica di budesonide e suo procedimento di preparazione.

Also Published As

Publication number Publication date
EP1604657A1 (en) 2005-12-14

Similar Documents

Publication Publication Date Title
CY2020013I2 (el) Φαρμακευτικη συνθεση που περιεχει γλυκοπυρρολικο και εναν αγωνιστη βητα2 αδρενοϋποδοχεα
DE602004016967D1 (de) Flüssige pharmazeutische palonosetronformulierungen
IL188732A (en) Use of ibuprofen and famotidine in the preparation of medicaments
EP1513825A4 (en) ANTITU-CULINARY MEDICAMENT: COMPOSITIONS AND METHODS
NO20054555D0 (no) Farmasoytiske preparater som omfatter syrestabilisert insulin
DK1957110T3 (da) Fremgangsmåde til fremstilling af tygbare doseringsformer til lægemiddeladministration og produkter dermed
DK2462972T3 (da) Nasal indgivelsesindretning
ITBO20050123A1 (it) Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
JP2007504142A5 (ja) Ｈｉｖプロテアーゼ阻害薬固体分散物を含む固体薬物剤形
MA28489B1 (fr) Preparations pharmaceutiques
CU20080052A7 (es) Formas de presentación farmacéutica sólidas de administración oral con liberación rápida de principio activo
NO20075628L (no) Farmasøytiske formuleringer
EP1965823A4 (en) METHOD FOR THE ADMINISTRATION OF HYPOGLYKEMIC AGENTS
DE60312049D1 (de) Stabilisierte pharmazeutische zusammensetzung enthaltend einen amorphen wirkstoff
DE502007005902D1 (de) -methyl-19-nor-20- spirox-4-en-3-one), sowie diese enthaltende pharmazeutische präparate
ATE477814T1 (de) Stabile faktor-viii enthaltende pharmazeutische zusammensetzung
DK1567137T3 (da) Anvendelse af resveratrol til fremstilling af et medikament, der er anvendeligt til behandling af influenzavirusinfektioner
BRPI0507225A2 (pt) formulações estáveis de solução farmacêutica para inaladores pressurizados de dose medida
DE602005007873D1 (de) Röntgensichtbare arzneimittelabgabevorrichtung
DE602004022810D1 (de) Mehrdosis-inhalator
NO20054214D0 (no) Iminoeterderivatforbindelser og legemidler inneholdende forbindelsene som den aktive bestanddel
EP1750693A4 (en) OKULOSELECTIVE MEDICINAL PRODUCTS AND PRODRUGS
ITRM20040268A1 (it) Formulazione farmaceutica di una soluzione stabile di formoterolo per via inalatoria e suo precedimento di preparazione.
DK2918286T3 (da) En farmaceutisk formulering
SM200500011B (it) Una composizione farmaceutica antimicobatterica